scholarly journals A randomized phase II study of aromatase inhibitors plus metformin in pre-treated postmenopausal patients with hormone receptor positive metastatic breast cancer

Oncotarget ◽  
2017 ◽  
Vol 8 (48) ◽  
pp. 84224-84236 ◽  
Author(s):  
Yannan Zhao ◽  
Chengcheng Gong ◽  
Zhonghua Wang ◽  
Jian Zhang ◽  
Leiping Wang ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Aromatase Inhibitors ◽  
Hormone Receptor ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Hormone Receptor Positive ◽  
Randomized Phase Ii

scholarly journals Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor–Positive Metastatic Breast Cancer: A Randomized Phase II Study

2011 ◽  
Vol 17 (5) ◽  
pp. 1147-1159 ◽  
Author(s):  
C. Kent Osborne ◽  
Patrick Neven ◽  
Luc Y. Dirix ◽  
John R. Mackey ◽  
Jean Robert ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Hormone Receptor ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Hormone Receptor Positive ◽  
Randomized Phase Ii

A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer

2020 ◽  
Vol 20 (3) ◽  
pp. 238-245 ◽  
Author(s):  
Romualdo Barroso-Sousa ◽  
Ian E. Krop ◽  
Lorenzo Trippa ◽  
Zhenying Tan-Wasielewski ◽  
Tianyu Li ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Hormone Receptor ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Palliative Radiotherapy ◽  
Hormone Receptor Positive
Sign in / Sign up

Export Citation Format

Share Document